Comparative effectiveness and safety of apixaban and rivaroxaban in cirrhosis and atrial fibrillation

被引:0
|
作者
Simon, Tracey G. [1 ]
Zhang, Yichi [2 ]
Mastrorilli, Julianna [3 ]
Cervone, Alexander [3 ]
Lin, Kueiyu Joshua [2 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
[3] Brigham & Womens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
143
引用
收藏
页码:56 / 57
页数:2
相关论文
共 50 条
  • [41] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol
    Luo, Xuemei
    Li, Xiaoyan
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan, Xianying
    Di Fusco, Manuela
    Garcia, Alessandra Bassalobre
    Yuce, Huseyin
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 435 - 435
  • [42] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
  • [43] Comparison of warfarin, dabigatran, rivaroxaban and apixaban for effectiveness and safety among elderly patients with atrial fibrillation: a nationwide cohort study
    Rutherford, O. C. W.
    Jonasson, C.
    Ghanima, W.
    Soderdahl, F.
    Halvorsen, S.
    EUROPEAN HEART JOURNAL, 2020, 41 : 662 - 662
  • [44] Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation
    Yang, Lanting
    Brooks, Maria M.
    Glynn, Nancy W.
    Zhang, Yuting
    Saba, Samir
    Hernandez, Inmaculada
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 126 : 29 - 36
  • [45] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
  • [46] Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation
    Yoshimura, Akino
    Iriki, Yasuhisa
    Ichiki, Hitoshi
    Oketani, Naoya
    Okui, Hideki
    Maenosono, Ryuichi
    Namino, Fuminori
    Miyata, Masaaki
    Ohishi, Mitsuru
    JOURNAL OF CARDIOLOGY, 2017, 69 (1-2) : 228 - 235
  • [47] REAL-WORLD COMPARATIVE EFFECTIVENESS AND SAFETY OF RIVAROXABAN AND WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS
    Laliberte, F.
    Cloutier, M.
    Nelson, W. W.
    Coleman, C., I
    Pilon, D.
    Olson, W. H.
    Damaraju, C., V
    Schein, J. R.
    Lefebvre, P.
    VALUE IN HEALTH, 2014, 17 (03) : A102 - A103
  • [48] Evaluation of safety and efficacy of perioperative use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation
    Iriki, Y.
    Ichiki, H.
    Oketani, N.
    Yoshimura, A.
    Okui, H.
    Maenosono, R.
    Namino, F.
    Miyata, M.
    Ohishi, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 687 - 687
  • [49] Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
    Laliberte, Francois
    Cloutier, Michel
    Nelson, Winnie W.
    Coleman, Craig I.
    Pilon, Dominic
    Olson, William H.
    Damaraju, C. V.
    Schein, Jeffrey R.
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1317 - 1325
  • [50] Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
    Gorst-Rasmussen, Anders
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (11) : 1236 - 1244